Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.42 - $0.72 $1,653 - $2,834
-3,937 Reduced 11.78%
29,488 $18,000
Q3 2023

Nov 02, 2023

SELL
$0.6 - $1.53 $27,679 - $70,583
-46,133 Reduced 57.99%
33,425 $20,000
Q2 2023

Jul 17, 2023

BUY
$1.05 - $1.63 $14,284 - $22,174
13,604 Added 20.63%
79,558 $89,000
Q4 2022

Feb 09, 2023

BUY
$1.71 - $3.61 $25,591 - $54,027
14,966 Added 29.35%
65,954 $123,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $14,935 - $67,840
7,861 Added 18.23%
50,988 $125,000
Q2 2022

Aug 03, 2022

BUY
$2.13 - $9.01 $21,191 - $89,640
9,949 Added 29.99%
43,127 $105,000
Q1 2022

May 03, 2022

BUY
$6.28 - $15.59 $67,805 - $168,325
10,797 Added 48.24%
33,178 $264,000
Q4 2021

Feb 01, 2022

SELL
$14.7 - $28.67 $73,955 - $144,238
-5,031 Reduced 18.35%
22,381 $342,000
Q3 2021

Oct 08, 2021

BUY
$24.31 - $33.6 $114,597 - $158,390
4,714 Added 20.77%
27,412 $779,000
Q2 2021

Aug 05, 2021

BUY
$26.09 - $40.4 $8,844 - $13,695
339 Added 1.52%
22,698 $766,000
Q1 2021

Apr 14, 2021

BUY
$33.06 - $56.93 $710,955 - $1.22 Million
21,505 Added 2518.15%
22,359 $854,000
Q1 2021

Apr 13, 2021

SELL
$33.06 - $56.93 $711,814 - $1.23 Million
-21,531 Reduced 96.18%
854 $32,000
Q4 2020

Feb 08, 2021

SELL
$39.09 - $57.4 $125,166 - $183,794
-3,202 Reduced 12.51%
22,385 $936,000
Q3 2020

Nov 12, 2020

BUY
$28.43 - $44.67 $337,122 - $529,696
11,858 Added 86.37%
25,587 $1.11 Million
Q2 2020

Jul 22, 2020

BUY
$11.71 - $30.29 $160,766 - $415,851
13,729 New
13,729 $416,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track F Dx Advisors, Inc. Portfolio

Follow F Dx Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.